Cell-derived vesicles to slow diabetes-related kidney aging

Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease

['FUNDING_R01'] · MAYO CLINIC JACKSONVILLE · NIH-11307651

Using tiny particles released by therapeutic cells to reduce inflammation and cellular aging that damage kidneys in people with diabetes.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorMAYO CLINIC JACKSONVILLE (nih funded)
Locations1 site (JACKSONVILLE, UNITED STATES)
Trial IDNIH-11307651 on ClinicalTrials.gov

What this research studies

Researchers plan to develop therapies made from extracellular vesicles (tiny packages) produced by mesenchymal stromal cells that carry protective microRNAs. They will test how these vesicles affect inflammation, immune cell infiltration, and senescent (aged) cells in models of diabetes-related kidney disease and aging. The team will measure effects on kidney structure and function and refine delivery approaches. The goal is to create senotherapeutics that could eventually be given to people to slow age-related kidney decline from diabetes.

Who could benefit from this research

Good fit: Adults with diabetes who are at risk for or have early-stage diabetic kidney disease and age-related kidney decline would be the most relevant candidates.

Not a fit: People with non-diabetic causes of kidney failure or those with advanced end-stage kidney disease are less likely to benefit from this therapy.

Why it matters

Potential benefit: If successful, this approach could slow or prevent diabetes-related kidney aging and help preserve kidney function, possibly delaying dialysis or transplant.

How similar studies have performed: Related cell-derived vesicle therapies have shown promising reductions in inflammation and senescence in animal studies, but human testing remains limited.

Where this research is happening

JACKSONVILLE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.